{"nct_id":"NCT01681992","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2012-10-10","start_date_type":"ACTUAL","primary_completion_date":"2015-02-03","primary_completion_date_type":"ACTUAL","completion_date":"2015-08-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}